These findings highlight PAI-1 as a significant marker for GBM prognosis, particularly pronounced within the proneural subtype, and identify PAI-1 as a GBM-intrinsic response to autophagy inhibition by lucanthone. The gene discussed is SERPINE1; the disease is glioblastoma.